Classification of Paclitaxel-Resistant Cell Lines Using Gene Expression Analysis and Machine Learning Techniques

Author:

Madiseh Ali Abedi,Saboori Somayeh,Shahsavari Shiva

Abstract

Abstract

This paper presents a comprehensive study on the classification of paclitaxel-resistant cell lines based on gene expression analysis and machine learning algorithms. The dataset used in this study was obtained from the NCBI - GEO datasets, comprising three datasets that included gene expression profiles of four paclitaxel-resistant cell lines: BAS, HS578T, MCF7, and MDA-MB-231. The gene expression data was preprocessed by converting gene identifiers to gene symbols and calculated adjusts p-value, t-test, B-test and logFC using R and also added cell lines. Subsequently, various machine learning classifiers, including Random Forest, Support Vector Machine (SVM), Gaussian Naive Bayes, K-Nearest Neighbors (KNN), Decision Tree, and AdaBoost, were employed to classify the paclitaxel-resistant cell lines. The performance of the classifiers was evaluated using accuracy scores and confusion matrices.The performance of these classifiers was assessed through accuracy scores and confusion matrices. Our results demonstrated that Random Forest and SVM achieved the highest accuracy scores, outperforming other algorithms. These findings suggest the potential of gene expression data and machine learning approaches in accurately classifying paclitaxel-resistant cell lines, which can aid in predicting drug resistance and developing targeted therapies for breast cancer treatment.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Microtubules as a target for anticancer drugs;Jordan MA;Nat Rev Cancer,2004

2. Paclitaxel (taxol);Rowinsky EK;N Engl J Med,1995

3. Microtubules and resistance to tubulin-binding agents;Kavallaris M;Nat Rev Cancer,2010

4. Drug resistance in breast cancer: Molecular mechanisms and novel targeted therapies;Singh SP;Int J Mol Sci,2017

5. Targeting cancer with small molecule kinase inhibitors;Zhang J;Nat Rev Cancer,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3